(Date:11/21/2008)...rsity of Texas Health Science Center at Houston wi...ing Studies (TEXAS), to promote geriatrics trainin...award from the Donald W. Reynolds Foundation and $... us to teach geriatric medicine principles to ever...icing physicians. With the reach of Lyndon B. John...
(Date:11/21/2008)...wire-FirstCall/ -- Heska Corporation,(Nasdaq: H...ork Society of,Security Analysts, 12th Annual Bio...2, 2008 at 1177 Avenue of the Americas, 2nd Floor ... begin at 9:35 a.m. Eastern Time (7:35 a.m.,Mount...nd for two weeks,following the presentation throu...
(Date:11/21/2008)...ire-USNewswire/ -- The Generic,Pharmaceutical Ass...oday from,GPhA President and CEO Kathleen Jaeger ...dtable on "Emerging Health Care Competition and Co...TC is conducting this roundtable demonstrates the,...ave access to safe and,affordable biogenerics soo...
(Date:11/21/2008)...ctive against Lennox-Gastaut syndrome , ,...alled Banzel (rufinamide) has been approved as a s...sy called Lennox-Gastaut syndrome, the U.S. Food a...approval was based on results of a four-month clin...mpared to patients who took a placebo, those who t...
Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:FDA Approves New Drug for Severe Epilepsy 2(Date:11/18/2008)...008 Faces of Influenza survey underscores that mot...nza; Mother and Gold Medalist Kristi Yamaguchi joi...ewswire/ -- While 78 percent of mothers in the Uni...ally life-threatening disease that can strike anyo... get vaccinated this season, according to a new su...
(Date:11/13/2008)...ional Supplements Prior to Surgery, ARLINGTON HEI...ntifying,malnutrition before surgery in massive we...gnificantly decrease surgical complications, accel...t patient energy levels,according to a study in t...rgery(R), the official medical journal of the Amer...
(Date:11/12/2008)...James D. Watson, Marilyn & James Simons and,Sherry...Md., Nov. 12 J. Craig V...g Venter Institute (JCVI), was,awarded the Double ...HL) on,November 6th at a gala event in New York Ci...long with Dr. James D.,Watson for making each of t...
(Date:11/12/2008)...tudy and New Data Suggesting Need for Improved ...Meeting -, EXTON, Pa., Nov. 12 /PRNewswire-FirstC...oday announced the presentation of data from its o...dy Cinryze(TM) C1 inhibitor,therapy successfully t...AE),attacks seen in the study through the date of ...
Breaking Medicine Technology:Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 3ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 4ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 5ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 6FDA Extends Review of Genasense 28R 29 NDA Appeal in Chronic Lymphocytic Leukemia 1190 1FDA Extends Review of Genasense 28R 29 NDA Appeal in Chronic Lymphocytic Leukemia 1190 2FDA Extends Review of Genasense 28R 29 NDA Appeal in Chronic Lymphocytic Leukemia 1190 3Schering Plough Reports Top Line Results of the IDEAL Study 1187 1Schering Plough Reports Top Line Results of the IDEAL Study 1187 2Schering Plough Reports Top Line Results of the IDEAL Study 1187 3Schering Plough Reports Top Line Results of the IDEAL Study 1187 4Schering Plough Reports Top Line Results of the IDEAL Study 1187 5Schering Plough Reports Top Line Results of the IDEAL Study 1187 6Schering Plough Reports Top Line Results of the IDEAL Study 1187 7Schering Plough Reports Top Line Results of the IDEAL Study 1187 8Schering Plough Reports Top Line Results of the IDEAL Study 1187 9Selective restraints and reduced medication could reduce nursing home falls says 4 year study 1877 1Selective restraints and reduced medication could reduce nursing home falls says 4 year study 1877 2U S Food Safety 3A Home Grown Problems Abound 9497 1U S Food Safety 3A Home Grown Problems Abound 9497 2U S Food Safety 3A Home Grown Problems Abound 9497 3U S Food Safety 3A Home Grown Problems Abound 9497 4U S Food Safety 3A Home Grown Problems Abound 9497 5U S Food Safety 3A Home Grown Problems Abound 9497 6...S OBISPO, Calif.--(BUSINESS WIRE)--Mar 22, 2007 - ... company,s research on,novel, synthetic dermal fil...World Congress (AAMWC) in Monte Carlo March,22-24,...iller, the first,ultra-smooth, non-permanent, synt...olymer science. Laresse represents a completely,ne...
...AD, Calif., March 22, 2007 /PRNewswire-FirstCall/ ...m three Phase 2 studies,of ISIS 301012, including ...rcholesterolemic (HoFH) patients, will be the subj...diology (ACC), March,24-27 in New Orleans. Planned...atients both as monotherapy and added to stable st...
Other Medicine Technology:Laresse Dermal Filler Research Presented at Anti-Aging World,Congress 2Isis Pharmaceuticals Announces Its Participation at the Upcoming,ACC 56th Annual Scientific Session in New Orleans and Its Live,Analyst/Investor Webcast Presentation 2Isis Pharmaceuticals Announces Its Participation at the Upcoming,ACC 56th Annual Scientific Session in New Orleans and Its Live,Analyst/Investor Webcast Presentation 3Isis Pharmaceuticals Announces Its Participation at the Upcoming,ACC 56th Annual Scientific Session in New Orleans and Its Live,Analyst/Investor Webcast Presentation 4Inquire
The MiniMed Paradigm REAL-Time System is the world's first system to integrate an insulin pump with REAL-Time continuous glucose monitoring, taking diabetes management to a level you just can't achie
The IEC CL30 Series from Thermo delivers maximum convenience and exceptional value for your low-speed clinical applications. With its unique AUTO-LOCK rotor exchange system, user-friendly controls, a
The IEC CL10 from Thermo is the ideal centrifuge for your low-speed clinical applications. With its broad choice of rotors, user-friendly controls, and generous sample capacity, the IEC CL10 delivers
Medicine Products: